EPS Diluted (Annual) Chart

View EPS Diluted (Annual) for POCI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Annual) Chart
Start Trial

Historical EPS Diluted (Annual) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2025 -0.8512
June 30, 2024 -0.4864
June 30, 2023 -0.0255
June 30, 2022 -0.1753
June 30, 2021 -0.0232
June 30, 2020 -0.3291
June 30, 2019 -0.1606
June 30, 2018 -0.12
June 30, 2017 -0.36
June 30, 2016 -0.4337
June 30, 2015 -0.57
June 30, 2014 -0.78
June 30, 2013 -1.53
June 30, 2012 2.34
Date Value
June 30, 2011 -3.18
June 30, 2010 -1.95
June 30, 2009 -2.91
June 30, 2008 -4.50
June 30, 2007 -11.25
June 30, 2006 -19.50
June 30, 2005 -41.25
June 30, 2004 -157.50
June 30, 2003 -125.25
June 30, 2002 -427.50
June 30, 2001 -162.00
June 30, 2000 -117.00
June 30, 1999 -112.50
June 30, 1998 -146.83

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Annual) Range, Past 5 Years

View EPS Diluted (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Annual) Benchmarks

View EPS Diluted (Annual) Benchmarks
Start Trial
RxSight, Inc. -0.9533
Abbott Laboratories 3.718
Align Technology, Inc. 5.653
AngioDynamics, Inc. -0.8848
Accuray, Inc. -0.4011